Orthofix Medical Inc. (OFIX) News

Orthofix Medical Inc. (OFIX): $18.68

0.19 (-1.01%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter OFIX News Items

OFIX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OFIX News Highlights

  • For OFIX, its 30 day story count is now at 4.
  • Over the past 16 days, the trend for OFIX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest OFIX News From Around the Web

Below are the latest news stories about ORTHOFIX MEDICAL INC that investors may wish to consider to help them evaluate OFIX as an investment opportunity.

Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures

According to Orthofix (OFIX), this data highlights the noninvasive and cost-effective nature of SpinalStim, enabling patients to continue their healing in the comfort of their homes.

Yahoo | December 27, 2023

Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis

LEWISVILLE, Texas, December 21, 2023--New data supports use of SpinalStim as adjunct therapy for patients at high risk of pseudarthrosis after lumbar spine fusion procedures.

Yahoo | December 21, 2023

Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company

LEWISVILLE, Texas, December 12, 2023--Orthofix Medical Inc. (NASDAQ: OFIX) ("Orthofix" or the "Company") today announced the appointment of three new independent directors to the Company’s Board. These new directors bring substantial finance, strategic development, healthcare and medical technology experience to further advance Orthofix’s position as a leading global spine and orthopedics company. The appointments follow constructive engagement and entry into a cooperation agreement with Engine

Yahoo | December 12, 2023

Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 72.2% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | December 11, 2023

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-

Yahoo | December 1, 2023

Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc

LEWISVILLE, Texas, November 29, 2023--Five-year data for the M6-C artificial cervical disc published in The Spine Journal. M6-C and M6-L discs implantations reach 100,000 worldwide.

Yahoo | November 29, 2023

Orthofix hires new CEO, 2 months after former leaders ousted

Massimo Calafiore is expected to join the spine and orthopedic device maker in early 2024 from Italy-based LimaCorporate.

Yahoo | November 28, 2023

Orthofix Names Massimo Calafiore as President and Chief Executive Officer

LEWISVILLE, Texas, November 28, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corpora

Yahoo | November 28, 2023

Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut

Orthofix (OFIX) saw very strong growth across multiple business segments and product lines in Q3.

Yahoo | November 24, 2023

Does Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 78.7% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | November 23, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!